Noëlle Dufour

3.2k total citations
33 papers, 2.4k citations indexed

About

Noëlle Dufour is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Noëlle Dufour has authored 33 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 24 papers in Cellular and Molecular Neuroscience and 7 papers in Neurology. Recurrent topics in Noëlle Dufour's work include Genetic Neurodegenerative Diseases (18 papers), Mitochondrial Function and Pathology (13 papers) and Virus-based gene therapy research (6 papers). Noëlle Dufour is often cited by papers focused on Genetic Neurodegenerative Diseases (18 papers), Mitochondrial Function and Pathology (13 papers) and Virus-based gene therapy research (6 papers). Noëlle Dufour collaborates with scholars based in France, Switzerland and United States. Noëlle Dufour's co-authors include Nicole Déglon, Philippe Hantraye, Emmanuel Brouillet, Gwennaëlle Aurégan, Raymonde Hässig, Sandro Alves, Gilles Bonvento, Luís Pereira de Almeida, Alexis‐Pierre Bemelmans and Isabel Nascimento-Ferreira and has published in prestigious journals such as Nature, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Noëlle Dufour

33 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Noëlle Dufour France 22 1.8k 1.6k 435 398 242 33 2.4k
Silvia Giovedı̀ Italy 26 1.4k 0.8× 976 0.6× 305 0.7× 369 0.9× 241 1.0× 42 2.5k
Xiao-Jiang Li United States 10 1.4k 0.8× 1.3k 0.8× 477 1.1× 282 0.7× 120 0.5× 15 2.0k
Gwennaëlle Aurégan France 16 1.1k 0.6× 1.0k 0.7× 306 0.7× 498 1.3× 476 2.0× 20 2.0k
Albert Giralt Spain 31 1.7k 0.9× 1.6k 1.0× 672 1.5× 447 1.1× 377 1.6× 73 2.8k
Tie-Shan Tang United States 21 2.3k 1.3× 1.5k 0.9× 456 1.0× 199 0.5× 111 0.5× 22 2.9k
Vikram G. Shakkottai United States 29 2.2k 1.2× 2.0k 1.2× 665 1.5× 368 0.9× 232 1.0× 68 3.1k
Stefania Fasano Italy 22 1.0k 0.6× 867 0.6× 277 0.6× 440 1.1× 251 1.0× 31 2.0k
Esther Pérez‐Navarro Spain 33 1.6k 0.9× 2.0k 1.2× 606 1.4× 235 0.6× 216 0.9× 90 2.8k
Gloria J. Klapstein United States 15 1.3k 0.7× 1.9k 1.2× 960 2.2× 259 0.7× 198 0.8× 18 2.5k
Giovanni Piccoli Italy 22 865 0.5× 684 0.4× 772 1.8× 365 0.9× 182 0.8× 60 1.8k

Countries citing papers authored by Noëlle Dufour

Since Specialization
Citations

This map shows the geographic impact of Noëlle Dufour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noëlle Dufour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noëlle Dufour more than expected).

Fields of papers citing papers by Noëlle Dufour

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noëlle Dufour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noëlle Dufour. The network helps show where Noëlle Dufour may publish in the future.

Co-authorship network of co-authors of Noëlle Dufour

This figure shows the co-authorship network connecting the top 25 collaborators of Noëlle Dufour. A scholar is included among the top collaborators of Noëlle Dufour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noëlle Dufour. Noëlle Dufour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cambon, Karine, Sylvain Martineau, Marie‐Claude Gaillard, et al.. (2017). Preclinical Evaluation of a Lentiviral Vector for Huntingtin Silencing. Molecular Therapy — Methods & Clinical Development. 5. 259–276. 13 indexed citations
2.
Mérienne, Nicolas, et al.. (2015). Gene transfer engineering for astrocyte-specific silencing in the CNS. Gene Therapy. 22(10). 830–839. 24 indexed citations
3.
Dufour, Noëlle, Sylvain Thierry, Olivier Delelis, et al.. (2014). Comparison Between Several Integrase-defective Lentiviral Vectors Reveals Increased Integration of an HIV Vector Bearing a D167H Mutant. Molecular Therapy — Nucleic Acids. 3. e213–e213. 7 indexed citations
4.
Francelle, Laetitia, Laurie Galvan, Marie‐Claude Gaillard, et al.. (2014). Loss of the thyroid hormone-binding protein Crym renders striatal neurons more vulnerable to mutant huntingtin in Huntington's disease. Human Molecular Genetics. 24(6). 1563–1573. 22 indexed citations
5.
Drouet, Valérie, Marta Ruiz, Diana Zala, et al.. (2014). Allele-Specific Silencing of Mutant Huntingtin in Rodent Brain and Human Stem Cells. PLoS ONE. 9(6). e99341–e99341. 45 indexed citations
6.
Dujardin, Simon, Katia Lécolle, Raphaëlle Caillierez, et al.. (2014). Neuron-to-neuron wild-type Tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies. Acta Neuropathologica Communications. 2(1). 14–14. 193 indexed citations
7.
Damiano, Maria, Elsa Diguet, Carole Malgorn, et al.. (2013). A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin. Human Molecular Genetics. 22(19). 3869–3882. 89 indexed citations
8.
Caillierez, Raphaëlle, Séverine Bégard, Katia Lécolle, et al.. (2013). Lentiviral Delivery of the Human Wild-type Tau Protein Mediates a Slow and Progressive Neurodegenerative Tau Pathology in the Rat Brain. Molecular Therapy. 21(7). 1358–1368. 26 indexed citations
9.
Galvan, Laurie, Marie‐Claude Gaillard, Carole Malgorn, et al.. (2012). Capucin does not modify the toxicity of a mutant Huntingtin fragment in vivo. Neurobiology of Aging. 33(8). 1845.e5–1845.e6. 6 indexed citations
10.
Nascimento-Ferreira, Isabel, Tiago Santos‐Ferreira, Lígia Sousa-Ferreira, et al.. (2011). Overexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado–Joseph disease. Brain. 134(5). 1400–1415. 162 indexed citations
11.
Faideau, Mathilde, Jae-Hwan Kim, Kerry Cormier, et al.. (2010). In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects. Human Molecular Genetics. 19(15). 3053–3067. 250 indexed citations
12.
Alves, Sandro, Isabel Nascimento-Ferreira, Noëlle Dufour, et al.. (2010). Silencing ataxin-3 mitigates degeneration in a rat model of Machado–Joseph disease: no role for wild-type ataxin-3?. Human Molecular Genetics. 19(12). 2380–2394. 83 indexed citations
13.
Drouet, Valérie, Valérie Perrin, Raymonde Hässig, et al.. (2009). Sustained effects of nonallele‐specific Huntingtin silencing. Annals of Neurology. 65(3). 276–285. 173 indexed citations
14.
Benchoua, Alexandra, Yaël Trioulier, Elsa Diguet, et al.. (2008). Dopamine determines the vulnerability of striatal neurons to the N-terminal fragment of mutant huntingtin through the regulation of mitochondrial complex II. Human Molecular Genetics. 17(10). 1446–1456. 54 indexed citations
15.
Drouet, Valérie, Valérie Perrin, Raymonde Hässig, et al.. (2008). Effects of long-term and global huntingtin silencing. Human Gene Therapy. 19(10). 1125–1126. 1 indexed citations
16.
Alves, Sandro, Etienne Régulier, Isabel Nascimento-Ferreira, et al.. (2008). Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease. Human Molecular Genetics. 17(14). 2071–2083. 67 indexed citations
17.
Faideau, Mathilde, Noëlle Dufour, Gwennaëlle Aurégan, et al.. (2008). Engineered lentiviral vector targeting astrocytes In vivo. Glia. 57(6). 667–679. 123 indexed citations
18.
Alves, Sandro, Isabel Nascimento-Ferreira, Gwennaëlle Aurégan, et al.. (2008). Allele-Specific RNA Silencing of Mutant Ataxin-3 Mediates Neuroprotection in a Rat Model of Machado-Joseph Disease. PLoS ONE. 3(10). e3341–e3341. 122 indexed citations
19.
Molles, Brian E., Uwe Maskos, Sebastián Pons, et al.. (2006). Targeted In Vivo Expression of Nicotinic Acetylcholine Receptors in Mouse Brain Using Lentiviral Expression Vectors. Journal of Molecular Neuroscience. 30(1-2). 105–106. 8 indexed citations
20.
Debeir, Thomas, Mario Gustavo Murer, Noëlle Dufour, et al.. (2002). Effect of Chronic Treatment with Riluzole on the Nigrostriatal Dopaminergic System in Weaver Mutant Mice. Experimental Neurology. 176(1). 247–253. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvia Giovedı̀ Breakdown of academic impact, for papers by Xiao-Jiang Li Breakdown of academic impact, for papers by Gwennaëlle Aurégan Breakdown of academic impact, for papers by Albert Giralt Breakdown of academic impact, for papers by Tie-Shan Tang Breakdown of academic impact, for papers by Vikram G. Shakkottai Breakdown of academic impact, for papers by Stefania Fasano Breakdown of academic impact, for papers by Esther Pérez‐Navarro Breakdown of academic impact, for papers by Gloria J. Klapstein Breakdown of academic impact, for papers by Giovanni Piccoli
Rankless by CCL
2026